Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5170654
Max Phase: Preclinical
Molecular Formula: C24H29N9O11
Molecular Weight: 619.55
Associated Items:
ID: ALA5170654
Max Phase: Preclinical
Molecular Formula: C24H29N9O11
Molecular Weight: 619.55
Associated Items:
Canonical SMILES: Cc1cn([C@H]2C[C@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](O)[C@@H]3O)[C@@H](CO)O2)c(=O)[nH]c1=O
Standard InChI: InChI=1S/C24H29N9O11/c1-8-4-32(24(42)31-20(8)39)12-2-9(11(5-34)43-12)29-21(40)10(3-13(35)36)30-22(41)17-15(37)16(38)23(44-17)33-7-28-14-18(25)26-6-27-19(14)33/h4,6-7,9-12,15-17,23,34,37-38H,2-3,5H2,1H3,(H,29,40)(H,30,41)(H,35,36)(H2,25,26,27)(H,31,39,42)/t9-,10+,11+,12+,15-,16+,17-,23+/m0/s1
Standard InChI Key: SOLIXMFSQLULOY-PZYMIOSESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 619.55 | Molecular Weight (Monoisotopic): 619.1987 | AlogP: -4.39 | #Rotatable Bonds: 9 |
Polar Surface Area: 299.13 | Molecular Species: ACID | HBA: 16 | HBD: 8 |
#RO5 Violations: 3 | HBA (Lipinski): 20 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.83 | CX Basic pKa: 4.96 | CX LogP: -4.77 | CX LogD: -7.36 |
Aromatic Rings: 3 | Heavy Atoms: 44 | QED Weighted: 0.11 | Np Likeness Score: 0.62 |
1. Das A, Dasgupta S, Pathak T.. (2022) Crescent-shaped meta-substituted benzene derivatives as a new class of non-nucleoside ribonuclease A inhibitors., 71 [PMID:35944385] [10.1016/j.bmc.2022.116888] |
Source(1):